ALLIANCEBERNSTEIN L.P. - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 174 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.42 and the average weighting 0.3%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$43,696,000
+8.9%
3,512,570
+19.9%
0.04%
+5.9%
Q3 2016$40,112,000
+1038.9%
2,930,036
+514.8%
0.03%
+1033.3%
Q2 2016$3,522,000
+61.0%
476,585
+39.3%
0.00%
+50.0%
Q1 2016$2,187,000
+13.0%
342,185
+10.5%
0.00%0.0%
Q4 2015$1,936,000
+7.0%
309,7850.0%0.00%0.0%
Q3 2015$1,809,000
-29.5%
309,785
-0.1%
0.00%0.0%
Q2 2015$2,565,000
+0.4%
310,1550.0%0.00%0.0%
Q1 2015$2,556,000
+19.9%
310,1550.0%0.00%0.0%
Q4 2014$2,131,000
+27.2%
310,1550.0%0.00%
+100.0%
Q3 2014$1,675,000
-15.2%
310,1550.0%0.00%
-50.0%
Q2 2014$1,976,000
+115.5%
310,155
+172.6%
0.00%
+100.0%
Q1 2014$917,000
+30.8%
113,756
+10.7%
0.00%0.0%
Q4 2013$701,000
-86.5%
102,767
-63.6%
0.00%
-80.0%
Q3 2013$5,199,000
+11.0%
282,539
+5.5%
0.01%0.0%
Q2 2013$4,684,000267,8100.01%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,000,000$96,720,00033.30%
Opaleye Management Inc. 1,670,000$13,460,0009.94%
Slate Path Capital LP 6,620,000$53,357,0004.04%
Granite Point Capital Management, L.P. 648,000$5,223,0003.74%
Palo Alto Investors LP 6,917,248$55,754,0002.30%
Camber Capital Management LP 3,000,000$24,180,0001.90%
Geduld E E 277,600$2,237,0001.21%
Elk Creek Partners, LLC 290,886$2,345,0001.01%
SELZ CAPITAL LLC 400,000$3,224,0000.81%
GENERAL AMERICAN INVESTORS CO INC 1,200,000$9,672,0000.81%
View complete list of ARIAD PHARMACEUTICALS INC shareholders